AKYNZEO Archives | Be Korea-savvy

Helsinn Announces Launch of Oral Formulation of Akynzeo® in China

Lugano, Switzerland, June 9 (Korea Bizwire) – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to announce that the oral formulation of Akynzeo® for the treatment of chemotherapy-induced nausea and vomiting (CINV) has been launched in China. Helsinn’s partner Mundipharma (China) Pharmaceutical Company Ltd. has exclusive marketing, promotion [...]

Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a Company of the Menarini Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS Region

Lugano, Switzerland and Berlin, Germany, Jan. 27 (Korea Bizwire) - Helsinn Group (“Helsinn”), a Swiss pharmaceutical group focused on building quality cancer care products, has granted exclusive licensing rights to commercialize AKYNZEO® and ONICIT® (ALOXI®) in Russia and the CIS region for the prevention of chemotherapy-induced nausea and vomiting (CINV) to Berlin-Chemie AG (“Berlin-Chemie”), the German-based affiliate of [...]